Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadar Kolb

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
JAMA Neurology|August 13, 2019
Association of Chronic Active Multiple Sclerosis Lesions With Disability In VivoMartina Absinta, Pascal Sati, Federica Masuzzo, et al.
Journal of Neuroimmunology|August 4, 2022
CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosisLior Fuchs, Karin Mausner-Fainberg, Anna Luban, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2023
New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 EncephalitisYahel Segal, Michal Nisnboym, Keren Regev, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2026
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trialAaron Miller, Jeffrey A Cohen, Arnon Karni, et al.
Investigative Radiology|June 4, 2021
Navigator-Guided Motion and B0 Correction of T2*-Weighted Magnetic Resonance Imaging Improves Multiple Sclerosis Cortical Lesion DetectionJiaen Liu, Erin S Beck, Stefano Filippini, et al.
Journal of Neurology|May 4, 2025
Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-upHadar Kolb, Yuval Shachaf, Karin Fainberg, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 18, 2024
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter StudyLior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 9, 2020
Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple SclerosisMaxime Donadieu, Hannah Kelly, Diego Szczupak, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 25, 2026
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategiesLior Fuchs, Ifat Vigiser, Hadar Kolb, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JAMA Neurology|August 13, 2019
Association of Chronic Active Multiple Sclerosis Lesions With Disability In VivoMartina Absinta, Pascal Sati, Federica Masuzzo, et al.
Journal of Neuroimmunology|August 4, 2022
CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosisLior Fuchs, Karin Mausner-Fainberg, Anna Luban, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2023
New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 EncephalitisYahel Segal, Michal Nisnboym, Keren Regev, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2026
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trialAaron Miller, Jeffrey A Cohen, Arnon Karni, et al.
Investigative Radiology|June 4, 2021
Navigator-Guided Motion and B0 Correction of T2*-Weighted Magnetic Resonance Imaging Improves Multiple Sclerosis Cortical Lesion DetectionJiaen Liu, Erin S Beck, Stefano Filippini, et al.
Journal of Neurology|May 4, 2025
Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-upHadar Kolb, Yuval Shachaf, Karin Fainberg, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 18, 2024
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter StudyLior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 9, 2020
Ultrahigh-resolution MRI Reveals Extensive Cortical Demyelination in a Nonhuman Primate Model of Multiple SclerosisMaxime Donadieu, Hannah Kelly, Diego Szczupak, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 25, 2026
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategiesLior Fuchs, Ifat Vigiser, Hadar Kolb, et al.
Pageof 3